The HR for CKD development associated with MAFLD was estimated to be 1.12 (95% confidence interval: 1.021.26, p = 0.027), indicating a statistically significant relationship between MAFLD and the risk of CKD, even when accounting for the aforementioned variables (76)
Clinical trials show average weight loss of 15-22% of body weight over 68 weeks when combining semaglutide with lifestyle modifications
Worldwide, the prevalence of AFib is increasing in both developed and developing countries
Inquire about warning signs that require urgent medical attention, such as severe abdominal pain, gallbladder symptoms (right upper quadrant pain, fever, yellowing of skin), allergic reactions, or signs of dehydration
Impact of lipid tail length on the organ selectivity of mRNA-lipid nanoparticles
By supplying your body with essential nutrients for cellular regeneration, we support your recovery journey